Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 247,000 | 258,000 | 117,000 | 112,000 | 383,000 |
| Gross Profit | 247,000 | 258,000 | 117,000 | 112,000 | 383,000 |
| Operating Expenses | 633,000 | 588,000 | 457,000 | 392,000 | 329,000 |
| Operating Income | -386,000 | -330,000 | -340,000 | -280,000 | 54,000 |
| Interest Expense | 8,000 | 4,000 | 2,000 | 2,000 | 0 |
| Other Income | 41,000 | 52,000 | 41,000 | 16,000 | 1,000 |
| Pre-tax Income | -353,000 | -282,000 | -301,000 | -266,000 | 55,000 |
| Income Tax | N/A | 1,000 | 6,000 | 1,000 | 2,000 |
| Net Income Continuous | -353,000 | -283,000 | -307,000 | -267,000 | 53,000 |
| Net Income | $-353,000 | $-283,000 | $-307,000 | $-267,000 | $53,000 |
| EPS Basic Total Ops | -3.29 | -3.14 | -4.15 | -3.71 | 0.76 |
| EPS Basic Continuous Ops | -3.29 | -3.14 | -4.15 | -3.71 | 0.76 |
| EPS Diluted Total Ops | -3.29 | -3.14 | -4.15 | -3.71 | 0.71 |
| EPS Diluted Continuous Ops | -3.29 | -3.14 | -4.15 | -3.71 | 0.72 |
| EPS Diluted Before Non-Recurring Items | -3.29 | -3.14 | -4.15 | -3.71 | 0.71 |
| EBITDA(a) | $-389,000 | $-345,000 | $-351,000 | $-274,000 | $63,000 |